(Q74645489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Effects of treatment with formoterol on bronchoprotection against methacholine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Baker

5

0 references

author name string

B Lipworth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Tan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Devlin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

T Aiken

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

D Hendrick

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

431-438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Functional antagonism: tolerance produced by inhaled beta 2 agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

The relationship between bronchial responsiveness to methacholine and bronchial responsiveness to histamine in asthmatic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Salmeterol tachyphylaxis in steroid treated asthmatic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900086-2

10.1016/S0002-9343(98)00086-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9626025%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference